You are here: Industry Insights > Indian

News List

Bharat buys GSK’s Indian vaccine unit to become largest rabies shot producer fiercepharma
February 19, 2019
India’s Bharat Biotech is about to become the world's largest supplier of rabies vaccines, thanks to a deal to buy Chiron Behring Vaccines from GlaxoSmithKline.
LANXESS to strengthen its Indian production sites expressbpd
November 17, 2018
Specialty chemicals company LANXESS is strengthening its asset base in India. The company plans to invest up to ₹ 1250 crores till 2023. Focus areas of the investment will be the businesses for chemical intermediates, high-performance plastics and water t
Depreciating Indian rupee to offer respite to pharma sector: Ind-Ra expressbpd
November 01, 2018
Ind-Ra expects the Indian rupee to continue weakening against the US dollar and, thus, support the top line growth of pharma companies and safeguard them from the margin pressure
China opens market to Indian drugs with reduced tariffs pharmafile
July 17, 2018
India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most populous countries.
Over 3% of all drugs in Indian market not up to standard pharmafile
July 25, 2017
The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that 946 of the medicines across 66 companies failed the test.
Indian Pharmacovigilance Day 2017 conference to be held in Hyderabad financialexpress
July 14, 2017
Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe, to chair the conference
Indian pharma industry scores poorly on Digital Savvy Reps Survey pharmaasia
June 14, 2017
The study covered over 500 healthcare reps across US, China, India and rest of the world
Following global tour, Zika virus knocks Indian doors biospectrumasia
May 31, 2017
India reports its first three cases of Zika virus from Ahmedabad
Malaria expected to be eradicated from 15 Indian states by 2020 pharmafile
May 15, 2017
In good news in the fight against antimalarial drug resistance, the Director of the National Vector Borne Disease Control Programme (NVBDCP) has announced that they expect a serious reduction in the numbers of people being infected by malaria over the nex
Indian biosimilar market likely to touch $1 billion in three years firstwordpharma
February 20, 2017
According to industry estimates, India's biosimilars market could exceed $1 billion by 2020, as reported Business Standard Sunday.

Previous page 1 2 Next page